These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 21082388

  • 1. Integrated platform for brain imaging and drug delivery across the blood-brain barrier.
    Iqbal U, Abulrob A, Stanimirovic DB.
    Methods Mol Biol; 2011; 686():465-81. PubMed ID: 21082388
    [Abstract] [Full Text] [Related]

  • 2. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K, Georgieva JV, Brinkhuis RP, van Hest JC, Rutjes FP, Dierckx RA, de Vries EF, Zuhorn IS.
    Mol Pharm; 2012 Jun 04; 9(6):1620-7. PubMed ID: 22536790
    [Abstract] [Full Text] [Related]

  • 3. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q.
    Mol Pharm; 2009 Jun 04; 6(3):905-17. PubMed ID: 19344115
    [Abstract] [Full Text] [Related]

  • 4. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 04; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X, Gao J, Zhan C, Xie C, Chai Z, Ran D, Ying M, Zheng P, Lu W.
    J Control Release; 2015 Nov 28; 218():13-21. PubMed ID: 26428462
    [Abstract] [Full Text] [Related]

  • 10. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
    Ché C, Yang G, Thiot C, Lacoste MC, Currie JC, Demeule M, Régina A, Béliveau R, Castaigne JP.
    J Med Chem; 2010 Apr 08; 53(7):2814-24. PubMed ID: 20210346
    [Abstract] [Full Text] [Related]

  • 11. Advances in strategies to improve drug delivery to brain tumors.
    Newton HB.
    Expert Rev Neurother; 2006 Oct 08; 6(10):1495-509. PubMed ID: 17078789
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
    Andrieux K, Couvreur P.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Oct 08; 1(5):463-74. PubMed ID: 20049811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M, McDannold N, Jolesz FA, Hynynen K.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1085-90. PubMed ID: 16403441
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.